CliffBio
small molecule

INVELTYS

LOTEPREDNOL ETABONATE

Loss of exclusivityMay 2033latest FDA-listed patent expiry
CompanyAlcon →View the full company profile on CliffBio

Drug detail

Brand nameINVELTYS
Active ingredientLOTEPREDNOL ETABONATE
Strength1%
Dosage formSUSPENSION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalAugust 2018
Marketing statusRX

Listed patents

PatentExpiresType
9056057May 2033product
9532955May 2033use U-2491
10058511May 2033product
11219597May 2033use U-3279
10864219May 2033use U-3011
9737491May 2033use U-2492
9827191May 2033product
12115246May 2033product
10688045May 2033product
11642317May 2033product
10646437May 2033product
9393213May 2033product
11872318May 2033product

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

INVELTYS patent cliff — loss of exclusivity May 2033 | CliffBio